LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (3)
Balyasny
$97.4M
added
Citadel
$95.6M
added
Point72
$39.2M
bought
Top-trader positions in EXPD could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 4, 2026
Financial period
Q2 2026
Earnings per share
$1.69 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
$2.04 to $2.42
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $2.03 / $1.69Yahoo Finance | +20.04% beat | $3.50B No estimate | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $1.71 / $1.33Yahoo Finance | +28.72% beat | $2.78B No estimate | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $1.49 / $1.46Yahoo Finance | +2.38% beat | $2.86B No estimate | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | $1.64 / $1.39Yahoo Finance | +17.60% beat | $2.89B No estimate | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $1.34 / $1.24Alpha Vantage | +8.06% beat | $2.65B No estimate | Unavailable |
| Mar 31, 2025 | May 6, 2025 | $1.47 / $1.37Alpha Vantage | +7.30% beat | $2.67B No estimate | Unavailable |
| Dec 31, 2024 | Feb 18, 2025 | $1.68 / $1.44Alpha Vantage | +16.74% beat | $2.95B No estimate | Unavailable |
| Sep 30, 2024 | Nov 5, 2024 | $1.63 / $1.35Alpha Vantage | +20.74% beat | $3.00B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.89B | $2.86B | $2.78B | $3.50B |
| Cost of what it sold | $2.43B | $2.44B | $1.81B | $2.48B |
| Gross profit | $464.7M | $413.3M | $971.8M | $1.03B |
| What it spent | ||||
| Sales and admin | $9.7M | $11.9M | $666.6M | $666.6M |
| Other operating costs | $167.0M | $150.4M | $10.4M | $9.9M |
| Total operating expenses | $176.6M | $162.4M | $677.0M | $676.5M |
| What was left | ||||
| Operating profit | $288.0M | $250.9M | $294.8M | $349.6M |
| Profit before tax | $298.2M | $262.0M | $306.5M | $357.4M |
| Tax | $75.1M | $61.1M | $76.4M | $91.2M |
| Net profit | $222.3M | $201.2M | $229.6M | $266.2M |
| EBITDA | $312.4M | $276.1M | $305.7M | $365.3M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Expeditors International of Washington, Inc. Estimates – NYSE:EXPD
NeutralOct 23UBS reiterates Expeditors stock Buy rating ahead of analyst day
BullishOct 23RXO, Inc. (RXO) Stock forecasts
Leans bullishOct 23Expeditors International of Washington, Inc. (EXPD) stock price, news, quote and history
Leans bullishOct 23Expeditors Named Gap Inc.’s 2025 Strategic Supplier of the Year for Operations Excellence
BullishOct 22West Pharmaceutical Services, I (WST) Stock Forecasts
Leans bullishOct 21Goldman Sachs raises target to USD 180.00 for Expeditors stock
Leans bullishOct 20Freightos Signs Agreement with mas to Expand Widebody Capacity and Streamline Payments Across Latin America
Leans bullishOct 20